Literature DB >> 10771980

Etretinate in the management of harlequin siblings.

R K Pejaver1, R S Prasad, A K Garg, A Jelly, S Shawkat.   

Abstract

Harlequin fetus is the severe form of congenital ichthyosis. There are very few reports of babies with this condition surviving the first few weeks of life. We treated two siblings who lived for 22 months and six weeks respectively. We started treatment with oral etretinate every early in their lives and achieved good improvement in the skin condition of these babies.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 10771980     DOI: 10.1007/bf02752311

Source DB:  PubMed          Journal:  Indian J Pediatr        ISSN: 0019-5456            Impact factor:   1.967


  16 in total

1.  American Academy of Pediatrics Committee on Drugs: Retinoid therapy for severe dermatological disorders.

Authors: 
Journal:  Pediatrics       Date:  1992-07       Impact factor: 7.124

2.  Etretinate therapy and thrombocytopenia.

Authors:  L Naldi; M Rozzoni; G Finazzi; P Pini; L Marchesi; T Cainelli
Journal:  Br J Dermatol       Date:  1991-04       Impact factor: 9.302

Review 3.  Retinoids, cancer, and the skin.

Authors:  P M Elias; M L Williams
Journal:  Arch Dermatol       Date:  1981-03

4.  Erythema multiforme-like eruptions associated with etretinate therapy.

Authors:  M David; M Sandbank; N J Lowe
Journal:  Clin Exp Dermatol       Date:  1989-05       Impact factor: 3.470

5.  Pseudoporphyria complicating etretinate therapy.

Authors:  A J McDonagh; C I Harrington
Journal:  Clin Exp Dermatol       Date:  1989-11       Impact factor: 3.470

6.  Management and follow-up of harlequin siblings.

Authors:  R S Prasad; R K Pejaver; A Hassan; S al Dusari; M A Wooldridge
Journal:  Br J Dermatol       Date:  1994-05       Impact factor: 9.302

7.  Premature epiphyseal closure--a complication of etretinate therapy in children.

Authors:  J Prendiville; E A Bingham; D Burrows
Journal:  J Am Acad Dermatol       Date:  1986-12       Impact factor: 11.527

8.  Surveillance for skeletal toxicity of children treated with etretinate.

Authors:  M T Glover; A M Peters; D J Atherton
Journal:  Br J Dermatol       Date:  1987-05       Impact factor: 9.302

9.  Etretinate-induced skeletal muscle damage.

Authors:  E Hodak; M David; N Gadoth; M Sandbank
Journal:  Br J Dermatol       Date:  1987-05       Impact factor: 9.302

10.  Harlequin baby treated with etretinate.

Authors:  M Rogers; C Scraf
Journal:  Pediatr Dermatol       Date:  1989-09       Impact factor: 1.588

View more
  2 in total

1.  Harlequin ichthyosis: a case report of prolonged survival.

Authors:  Anwar A Mithwani; Asif Hashmi; Shahid Shahnawaz; Yasser Al Ghamdi
Journal:  BMJ Case Rep       Date:  2014-03-07

2.  Consensus recommendations for the use of retinoids in ichthyosis and other disorders of cornification in children and adolescents.

Authors:  Andrea L Zaenglein; Moise L Levy; Nicole S Stefanko; Latanya T Benjamin; Anna L Bruckner; Keith Choate; Brittany G Craiglow; John J DiGiovanna; Lawrence F Eichenfield; Peter Elias; Philip Fleckman; Leslie P Lawley; Richard A Lewis; Anne W Lucky; Erin F Mathes; Leonard M Milstone; Amy S Paller; Sonali S Patel; Dawn H Siegel; Joyce Teng; Sherry A Tanumihardjo; Lauren Thaxton; Mary L Williams
Journal:  Pediatr Dermatol       Date:  2020-11-10       Impact factor: 1.588

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.